Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
A Phase 3, Multicenter, Placebo-Controlled, Randomized, Observer-Blinded Trial to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) (VALOR)
Date:
Topics:
Lead Investigators:
